Short answer
Teleflex Inc (TFX) filed an 8-K current report with the SEC on March 17, 2026 reporting Item 8.01 (Other Events). OEM Transaction (buyer: Montagu PE + Kohlberg & Co. affiliate) cleared HSR antitrust review Mar 13; closing targeted Q3 2026.
Teleflex Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- OEM Transaction (buyer: Montagu PE + Kohlberg & Co. affiliate) cleared HSR antitrust review Mar 13; closing targeted Q3 2026
- Acute Care & Urology Transaction (buyer: Intersurgical Limited) hit FTC Second Request on Mar 11; signals heightened regulatory scrutiny, extending HSR waiting period materially
- FTC Second Request delays Acute Care & Urology closing; now contingent on 30-day post-compliance period, pushing timeline to "second half 2026" at earliest
- Two divestitures are independent transactions: OEM deal can close without resolution of Acute Care & Urology regulatory review
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Teleflex Inc 8-K filings
Get the next TFX 8-K as it lands
Follow TFX for push alerts, or ask the research agent what this filing means.